小方治疗原发性高血压病的临床研究  

Clinical study on treating essential hypertension with TCM prescription

作　　者：韩同坤 吴科[1] 李华伟[1] 李婵丽 Han Tongkun

机构地区：[1]深圳市宝安区松岗人民医院,广东深圳518105

出　　处：《中医临床研究》2020年第2期38-40,共3页Clinical Journal Of Chinese Medicine

基　　金：深圳市宝安区科技创新项目(项目编号:2017JD181),项目标题:基于人体空间医学理论的自拟小方治疗原发性高血压病的临床研究。

摘　　要：目的:探究小方治疗原发性高血压病的临床疗效。方法:本研究选择2017年5月-2018年5月于本院进行治疗的原发性高血压病患者60例,并将患者随机分为空白组、对照组及治疗组;其中空白组服用维生素C片起安慰作用,对照组患者服用苯磺酸左旋氨氯地平片,治疗组患者采用苯磺酸左旋氨氯地平片联合小方治疗;比较三组患者在治疗4周后的临床效果;测定三组患者治疗前及治疗后第1周、2周、3周及4周分别测定三组患者的收缩压和心率;对两组患者治疗前后第4周的头晕、头痛、胸闷、心悸、失眠等状况进行中医临床症状评分。结果:与对照组患者相比,研究组患者的临床疗效显著改善(P<0.05),血压、心率显著降低(P<0.05),中医证候评分显著降低(P<0.05)。结论:小方在原发性高血压病的治疗中发挥一定的作用,临床疗效显著。Objective:To explore the clinical efficacy of TCM prescription on essential hypertension.Methods:60 patients with primary hypertension treated in our hospital in May 2017-May 2018 were selected.According to the random digital table method,the patients were divided into the treatment group,the control group and the blank group,20 cases in each group.The blank group was given a placebo(vitamin C),the control group was given Levamlodipine Besylate Tablets,and the treatment group was treated with TCM prescription plus Levamlodipine Besylate Tablets.Results:Clinical efficacy in the study group was most improved(P<0.05),the blood pressure and heart rate are most decreased(P<0.05),and the TCM syndrome score was reduced(P<0.05).Conclusion:TCM prescription was effective on essential hypertension.

关 键 词：郭志辰 人体空间医学 小方 原发性高血压病 临床疗效 

分 类 号：R544.1[医药卫生—心血管疾病]